Literature DB >> 28762097

A Missense Variant p.Ala117Ser in the Transthyretin Gene of a Han Chinese Family with Familial Amyloid Polyneuropathy.

Qian Chen1,2,3, Lamei Yuan1, Xiong Deng1, Zhijian Yang1, Shengwang Zhang4, Sheng Deng1, Hongwei Lu5, Hao Deng6,7.   

Abstract

Familial amyloid polyneuropathy (FAP) is a dominantly inherited disorder. This study aims to explore the genetic features of a Han Chinese family with FAP, characterized by bloating, alternating diarrhea and constipation, and weakness in his feet. Amyloid presented histologically in the vessel walls of hepatic portal area and nerves of the surgically excised liver specimens from the proband by hematoxylin and eosin staining. Amyloid deposition was further confirmed with Congo red treatment. A c.349G>T transversion (p.Ala117Ser) in TTR gene exon 4 was identified in the proband with typical autonomic neuropathy and peripheral motor neuropathy, as well as in his asymptomatic son. The variant was not detected in 200 normal ethnically matched controls. These findings provide new insights into FAP cause and diagnosis and have implications for genetic counseling.

Entities:  

Keywords:  Familial amyloid polyneuropathy; Liver transplantation; Missense variant; The TTR gene

Mesh:

Substances:

Year:  2017        PMID: 28762097     DOI: 10.1007/s12035-017-0694-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  47 in total

1.  Misfolded transthyretin causes behavioral changes in a Drosophila model for transthyretin-associated amyloidosis.

Authors:  Malgorzata Pokrzywa; Ingrid Dacklin; Dan Hultmark; Erik Lundgren
Journal:  Eur J Neurosci       Date:  2007-08       Impact factor: 3.386

2.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

Authors:  C ANDRADE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

3.  Parent-of-origin effect in transthyretin related amyloid polyneuropathy.

Authors:  Bernard Bonaïti; Flora Alarcon; Catherine Bonaïti-Pellié; Violaine Planté-Bordeneuve
Journal:  Amyloid       Date:  2009       Impact factor: 7.141

Review 4.  The transthyretin amyloidoses: advances in therapy.

Authors:  Simon Dubrey; Elizabeth Ackermann; Julian Gillmore
Journal:  Postgrad Med J       Date:  2015-06-05       Impact factor: 2.401

5.  Genetic analysis of the RAB39B gene in Chinese Han patients with Parkinson's disease.

Authors:  Lamei Yuan; Xiong Deng; Zhi Song; Zhijian Yang; Bin Ni; Yong Chen; Hao Deng
Journal:  Neurobiol Aging       Date:  2015-06-19       Impact factor: 4.673

6.  Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding.

Authors:  Masanori Miyata; Takashi Sato; Mineyuki Mizuguchi; Teruya Nakamura; Shinji Ikemizu; Yuko Nabeshima; Seiko Susuki; Yoshiaki Suwa; Hiroshi Morioka; Yukio Ando; Mary Ann Suico; Tsuyoshi Shuto; Tomoaki Koga; Yuriko Yamagata; Hirofumi Kai
Journal:  Biochemistry       Date:  2010-01-12       Impact factor: 3.162

7.  CPHmodels-3.0--remote homology modeling using structure-guided sequence profiles.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund; Thomas Nordahl Petersen
Journal:  Nucleic Acids Res       Date:  2010-06-11       Impact factor: 16.971

Review 8.  TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies.

Authors:  David Adams; Cecile Cauquil; Céline Labeyrie; Guillemette Beaudonnet; Vincent Algalarrondo; Marie Théaudin
Journal:  Expert Opin Pharmacother       Date:  2016-03-10       Impact factor: 3.889

9.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Yi; K Takahashi; M Naito; F Tashiro; S Wakasugi; S Maeda; K Shimada; K Yamamura; S Araki
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

10.  Uncovering the Mechanism of Aggregation of Human Transthyretin.

Authors:  Lorena Saelices; Lisa M Johnson; Wilson Y Liang; Michael R Sawaya; Duilio Cascio; Piotr Ruchala; Julian Whitelegge; Lin Jiang; Roland Riek; David S Eisenberg
Journal:  J Biol Chem       Date:  2015-10-12       Impact factor: 5.157

View more
  6 in total

1.  The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.

Authors:  Kuan Fan; Haixia Zhu; Hongbo Xu; Ping Mao; Lamei Yuan; Hao Deng
Journal:  J Neurol       Date:  2018-11-23       Impact factor: 4.849

2.  Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.

Authors:  Nath Pasutharnchat; Chamaiporn Taychargumpoo; Yongkasem Vorasettakarnkij; Jakkrit Amornvit
Journal:  BMC Neurol       Date:  2021-05-22       Impact factor: 2.474

3.  Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.

Authors:  Kang Du; Fan Li; Hui Wang; Yuanfeng Miao; He Lv; Wei Zhang; Zhaoxia Wang; Yun Yuan; Lingchao Meng
Journal:  Ann Clin Transl Neurol       Date:  2021-03-19       Impact factor: 4.511

4.  Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China.

Authors:  Xinyue He; Zhuang Tian; Hongzhi Guan; Shuyang Zhang
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

5.  Fluorotryptophan Incorporation Modulates the Structure and Stability of Transthyretin in a Site-Specific Manner.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2017-09-28       Impact factor: 3.162

6.  Extended Study of NUS1 Gene Variants in Parkinson's Disease.

Authors:  Lamei Yuan; Xiangyu Chen; Zhi Song; Weidong Le; Wen Zheng; Xin Liu; Hao Deng
Journal:  Front Neurol       Date:  2020-10-27       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.